Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abaxis Inc (ABAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 1,161,039
  • Shares Outstanding, K 22,650
  • Annual Sales, $ 227,220 K
  • Annual Income, $ 32,720 K
  • 36-Month Beta 0.84
  • Price/Sales 5.16
  • Price/Cash Flow 31.57
  • Price/Book 4.39

Price Performance

See More
Period Period Low Period High Performance
1-Month
50.29 +1.41%
on 07/20/17
54.08 -5.70%
on 06/30/17
-2.11 (-3.97%)
since 06/27/17
3-Month
44.12 +15.59%
on 05/01/17
54.08 -5.70%
on 06/30/17
+1.65 (+3.34%)
since 04/27/17
52-Week
44.12 +15.59%
on 05/01/17
55.95 -8.85%
on 12/13/16
+1.86 (+3.79%)
since 07/27/16

Most Recent Stories

More News
Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More

The market remained jittery towards medical space due to uncertainties surrounding the future of the healthcare act.

ABT : 50.15 (-0.50%)
ABAX : 52.08 (+1.60%)
ATHN : 143.13 (-1.80%)
ISRG : 941.12 (-0.30%)
Abaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday, July 27, 2017

Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, has scheduled a conference...

ABAX : 52.08 (+1.60%)
Abaxis (ABAX) Product Portfolio Strong, Competition Rife

On Jun 28, we issued an updated research report on California-based Abaxis, Inc. (ABAX).

AXDX : 27.50 (-0.72%)
ABAX : 52.08 (+1.60%)
ALGN : 157.40 (-0.81%)
INGN : 95.70 (+0.01%)
Veterinary Hematology Analyzers Market to Reach US$1,178.9 Million by 2024: Rising Expenditure on Animal Healthcare Key to Growth

The global market for Veterinary Hematology Analyzers features a largely consolidated vendor landscape, with the top three players accounting for nearly 51% of the overall market in 2015, observes Transparency...

ABAX : 52.08 (+1.60%)
Global POC Lipid Testing Market to Grow at a CAGR of 6.28%, 2017-2021 with Alere, F. Hoffmann-La Roche & Abaxis Leading the Market - Research and Markets

Research and Markets has announced the addition of the "Global POC Lipid Testing Market 2017-2021" report to their offering.

ABAX : 52.08 (+1.60%)
New Strong Sell Stocks for May 2nd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

MDCA : 10.40 (+1.96%)
AYI : 203.40 (+0.22%)
AMSF : 57.10 (-0.44%)
ABAX : 52.08 (+1.60%)
ETH : 31.75 (+3.08%)
Abaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In Line

Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2017 adjusted earnings per share of 33 cents, a penny ahead of the Zacks Consensus Estimate.

ZLTQ : 56.48 (unch)
ABAX : 52.08 (+1.60%)
HRC : 81.62 (-1.16%)
INGN : 95.70 (+0.01%)
Abaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported financial...

ABAX : 52.08 (+1.60%)
Abaxis To Report Fourth Quarter And Fiscal Year 2017 Financial Results On Thursday, April 27, 2017

Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, has scheduled a conference...

ABAX : 52.08 (+1.60%)
New Strong Sell Stocks for March 1st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

SUMR : 1.69 (+0.60%)
BRFS : 11.89 (+0.08%)
ACHC : 49.29 (+0.06%)
ABAX : 52.08 (+1.60%)
AKR : 29.59 (-0.13%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Steady.

See More

Business Summary

Abaxis, Inc. develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The Company's primary product is a system consisting of a compact 6.9 kilogram analyzer and a series of single-use plastic...

See More

Support & Resistance

2nd Resistance Point 52.15
1st Resistance Point 51.71
Last Price 52.08
1st Support Level 50.91
2nd Support Level 50.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.